Lauren DAngelo
Chief Operating Officer bei ALPHA COGNITION INC.
Profil
Lauren DAngelo is currently the Chief Operating Officer at Alpha Cognition, Inc. She previously worked as the Vice President-Marketing & Commercial Strategy at Urovant Sciences, Inc. Ms. DAngelo completed her undergraduate degree at Florida State University and holds an MBA from the University of Florida.
Aktive Positionen von Lauren DAngelo
| Unternehmen | Position | Beginn |
|---|---|---|
| ALPHA COGNITION INC. | Chief Operating Officer | 01.01.2023 |
Ehemalige bekannte Positionen von Lauren DAngelo
| Unternehmen | Position | Ende |
|---|---|---|
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Sales & Marketing | - |
Ausbildung von Lauren DAngelo
| Florida State University | Undergraduate Degree |
| University of Florida | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
